| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2014 | US8642567 Receptor modulators exhibiting neuroprotective and memory enhancing activities |
| 02/04/2014 | US8642566 Therapeutic approaches for treating neuroinflammatory conditions |
| 02/04/2014 | US8642564 Compositions for drug administration |
| 02/04/2014 | US8642563 Mixture and infusion or drink solution |
| 02/04/2014 | US8642562 Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| 02/04/2014 | US8642542 Recombinant fusion proteins to growth hormone and serum albumin |
| 02/04/2014 | US8642534 Proteins and polynucleotides of Vibrio cholerae |
| 02/04/2014 | US8642533 Methods of nourishing animals |
| 02/04/2014 | US8642278 Inhibition of cell proliferation |
| 02/04/2014 | US8642093 Methods and systems for use of photolyzable nitric oxide donors |
| 02/04/2014 | US8642088 Tannin-chitosan composites |
| 02/04/2014 | US8642087 Compounds and methods for reducing oxidative stress |
| 02/04/2014 | US8642086 Antimicrobial compositions, methods of preparation thereof, and uses thereof |
| 02/04/2014 | US8642082 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 02/04/2014 | US8642081 Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance |
| 02/04/2014 | US8642079 Solid formulations of ospemifene |
| 02/04/2014 | US8642078 Coated formulations for tolterodine |
| 02/04/2014 | US8642077 Stable pharmaceutical composition and methods of using same |
| 02/04/2014 | US8642075 Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof |
| 02/04/2014 | US8642073 Encochleation methods, cochleates and methods of use |
| 02/04/2014 | US8642069 Composition and method for treating colds |
| 02/04/2014 | US8642063 Implantable medical device coatings with biodegradable elastomer and releasable taxane agent |
| 02/04/2014 | US8642050 Gonococcal proteins and nucleic acids |
| 02/04/2014 | US8642036 Treatment with anti-ErbB2 antibodies |
| 02/04/2014 | US8642026 Methods and compositions for contributing to the treatment of cancers |
| 02/04/2014 | US8642025 Hepatitis C virus inhibitors |
| 02/04/2014 | US8642024 Cosmetic composition comprising at least one organic structuring agent, at least one absorbent mixture and at least one surfactant for application to keratin materials |
| 02/04/2014 | US8642023 Skin cosmetic |
| 02/04/2014 | US8642022 Copolymers of epoxy compounds and amino silanes |
| 02/04/2014 | US8641816 Vinyl ether compounds and methods of their preparation and use |
| 02/04/2014 | US8641193 Spectral contrast for glaucoma imaging |
| 02/04/2014 | CA2770489C Bisphosphonate conjugates and methods of making and using the same |
| 02/04/2014 | CA2753405C Nitrogen-containing bicyclic heteroaryl compounds and methods of use |
| 02/04/2014 | CA2744221C Antagonists of lysophosphatidic acid receptors |
| 02/04/2014 | CA2743920C Composition for preventing adhesion |
| 02/04/2014 | CA2706742C Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 02/04/2014 | CA2702297C Novel crystalline forms of the anti-cancer compound zd1839 |
| 02/04/2014 | CA2697520C Use of lyophilised reduced diaminophenothiazines in the treatment of tau mediated neurological disorders |
| 02/04/2014 | CA2671979C Pharmaceutical composition containing low-substituted hydroxypropyl cellulose |
| 02/04/2014 | CA2666750C Phenylpropionamide compounds and the use thereof |
| 02/04/2014 | CA2656017C Use of pyridone derivatives in the prevention and treatment of radiation-induced lung injuries |
| 02/04/2014 | CA2655403C Antibacterial benzothiazoles and thiazolopyridines |
| 02/04/2014 | CA2647990C New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof |
| 02/04/2014 | CA2645070C Pharmaceutical composition for external use |
| 02/04/2014 | CA2641769C Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2-(2-chloro-4-{[(r)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]methyl}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders |
| 02/04/2014 | CA2624450C Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/04/2014 | CA2620032C Polymer conjugates of k-252a and derivatives thereof |
| 02/04/2014 | CA2618633C Adenine derivatives |
| 02/04/2014 | CA2610948C Compositions and methods for treating diverticular disease |
| 02/04/2014 | CA2608171C Use of quinolinone compounds for treating drug resistant cancers |
| 02/04/2014 | CA2607561C Pharmaceutical composition |
| 02/04/2014 | CA2607426C Fused thiazole derivatives as kinase inhibitors |
| 02/04/2014 | CA2606890C Immunogens for meningitidis-a vaccines |
| 02/04/2014 | CA2605847C Ddp-iv inhibitors for the treatment of postprandial hyperlipidemia |
| 02/04/2014 | CA2603534C Design and synthesis of novel antimicrobials |
| 02/04/2014 | CA2573969C Oxidative degradation products of atorvastatin calcium |
| 02/04/2014 | CA2543530C Use of biocompatible polymers for the preparation of a composition or a medical device |
| 02/04/2014 | CA2539273C A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 02/04/2014 | CA2498260C Pharmaceutical formulations of modafinil |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 02/04/2014 | CA2453470C Use of follistatin for the treatment of hepatic fibrogenesis |
| 02/04/2014 | CA2442533C A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/04/2014 | CA2432797C Local regional chemotherapy and radiotherapy using in situ hydrogel |
| 02/03/2014 | DE202012012822U1 Empfängnisverhütungs-Set zur aufeinanderfolgenden täglichen Anwendung Contraceptive kit for consecutive daily application |
| 01/30/2014 | WO2014018979A1 Inhibitors of histone deacetylase |
| 01/30/2014 | WO2014018953A1 Inauhzin analogues that induce p53, inhibit cell growth, and have antitumor activity |
| 01/30/2014 | WO2014018926A1 Methods and compositions for determining resistance to androgen receptor therapy |
| 01/30/2014 | WO2014018925A1 Compositions and methods for treating microbial infections |
| 01/30/2014 | WO2014018919A1 Seriniquinones, melanoma-specific anticancer agents |
| 01/30/2014 | WO2014018913A2 Santacruzamate a compositions and analogs and methods of use |
| 01/30/2014 | WO2014018891A1 Compounds that are s1p modulating agents and/or atx modulating agents |
| 01/30/2014 | WO2014018888A1 4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as tak1 inhibitors in disease treatment |
| 01/30/2014 | WO2014018887A1 Atx modulating agents |
| 01/30/2014 | WO2014018881A1 Atx modulating agents |
| 01/30/2014 | WO2014018874A1 Method for treating skin cancer |
| 01/30/2014 | WO2014018873A2 Compositions comprising folic acid derivatives. their preparations and methods of use |
| 01/30/2014 | WO2014018862A1 Pharmaceutical compositions comprising a heat shock protein inhibitor and a|purine de novo synthesis inhibitor for treating rheumatoid arthritis or cancer |
| 01/30/2014 | WO2014018856A1 Compositions and treatment for eye diseases and disorders |
| 01/30/2014 | WO2014018801A1 Diagnosis and treatment of cancer using differentially expressed starvation markers |
| 01/30/2014 | WO2014018765A1 Therapeutic compounds |
| 01/30/2014 | WO2014018764A1 Spiro - fused piperidine derivatives for use as inhibitors of the renal outer medullary potassium channel |
| 01/30/2014 | WO2014018741A1 Heterocyclic flavone derivatives, compositions, and methods related thereto |
| 01/30/2014 | WO2014018725A1 Pharmaceutical combinations of a cdk4/6 inhibitor and a b-raf inhibitor |
| 01/30/2014 | WO2014018695A1 Cannabinoid receptor antagonists/inverse agonists |
| 01/30/2014 | WO2014018671A1 Therapeutic compounds for the treatment of cancer |
| 01/30/2014 | WO2014018668A2 Aerosol pirfenidone and pyridone analog compounds and uses thereof |
| 01/30/2014 | WO2014018571A2 Use of cse inhibitors for the treatment of cutaneous injuries or conditions and sleep-related breathing disorders |
| 01/30/2014 | WO2014018570A1 Cystathionine-υ-lyase (cse) inhibitors |
| 01/30/2014 | WO2014018569A1 Cystathionine-y-gamma-lyase (cse) inhibitors |
| 01/30/2014 | WO2014018563A2 Methods for the treatment of cancer |
| 01/30/2014 | WO2014018549A2 Systems and methods for treatment of androgenetic skin conditions by microbial organisms |
| 01/30/2014 | WO2014018478A1 Compositions and formulations of glucosamine for transdermal and transmucosal administration |
| 01/30/2014 | WO2014018468A1 Modulation sapp, sapp alpha and bdnf levels in individuals diagnosed with fxs and asd |
| 01/30/2014 | WO2014018449A1 Substituted naphthyridinedione derivatives as hiv integrase inhibitors |
| 01/30/2014 | WO2014018417A1 Topical sanitizing formulations and uses thereof |
| 01/30/2014 | WO2014018355A1 Treating diabetes with dipeptidyl peptidase-iv inhibitors |
| 01/30/2014 | WO2014018350A1 Treating diabetes with dipeptidyl peptidase-iv inhibitors |
| 01/30/2014 | WO2014018223A1 Pharmaceutical formulation for bedwetting and method of use thereof |
| 01/30/2014 | WO2014018222A1 Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
| 01/30/2014 | WO2014018020A1 Cellulosic material preservatives containing disaccharide |